WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1632972
PLYMOUTH, MN
Position in NBIX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$12,066,621
+$1,489,349 QoQ
Shares Held
71,595
-10.8% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#6
of 76 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 2.097911865353726.ToString("F0")%
Shared 0.ToString("F0")%
None 97.90208813464628.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $45,863,285 across 32 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (26.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
71,595 | $12,066,621 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
16,933 | $9,174,807 | |
| 3 | ZTS |
Zoetis Inc.
|
83,719 | $6,016,047 | |
| 4 | VTRS |
Viatris Inc
|
362,617 | $5,758,357 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
20,499 | $1,310,911 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
59,123 | $1,023,419 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
219,445 | $923,863 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
7,760 | $860,894 |
All Filings in NBIX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,066,621 | 71,595 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $10,577,272 | 80,289 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $7,714,559 | 54,393 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $5,735,786 | 40,859 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,401,558 | 19,107 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $642,143 | 5,806 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $2,304,939 | 16,886 | Shares | Sole | 2025-03-17 | |
| 2024-09-30 | $650,532 | 5,646 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $875,168 | 6,357 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $654,292 | 4,744 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $420,841 | 3,194 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $323,775 | 2,878 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||